XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
BANGKOK,Feb. 13,2025-- Agoda reveals Thai couples to be leading in domestic travel compared to couples from other Asian markets this Valentine\'s Day. Thai couples are followed by those from Japan an
ASEAN Investment Challenge (AIC) 2024 brings together more than 5,000 higher education students for an insightful journey into responsible investing
SINGAPORE,Feb. 13,2025-- Mega Matrix Inc. (NYSE American: MPU)\'s globally leading short series streaming platform,FlexTV,has launched a romantic miniseries exploring love,responsibility,and redempti
CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi
TOKYO,Feb. 13,2025-- Applibot,Inc. (Headquarters: Shibuya,Tokyo; President: Koki Ukita) is launching a smartphone app "Chiikawa Pocket," in 43 countries and regions worldwide in late March 2
